Cerenkov luminescence imaging is an effective preclinical tool for assessing colorectal cancer PD-L1 levels in vivo

ConclusionsThere is a great potential for131I-PD-L1-Mab noninvasive Cerenkov luminescence imaging to assess the status of tumor PD-L1 expression and select patients for anti-PD-L1 targeted therapy.

http://link.springer.com/10.1186/s13550-020-00654-w

Source: EJNMMI Research - June 14, 2020 Category: Radiology Source Type: research